Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",26960,100,1.07 [0.77-1.50],0.6824103849788302
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27517,143,1.35 [1.03-1.78],0.0318331483443578
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27266,972,1.14 [1.02-1.27],0.0173872709319024
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Candidiasis,27547,297,1.19 [0.99-1.43],0.0640848510358506
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26772,2704,1.08 [1.01-1.15],0.0253607066396457
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27018,2040,1.20 [1.12-1.29],9.229537024122504e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,27342,983,1.06 [0.95-1.18],0.3207225543556623
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,27465,45,1.93 [1.24-3.00],0.0033348317397747
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26305,625,1.17 [1.02-1.34],0.0202765795154258
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25440,601,1.12 [0.98-1.28],0.0985741851944387
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,25677,166,1.28 [1.00-1.63],0.046903193573928
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,20536,1185,1.20 [1.09-1.32],0.0002223849737103
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,25446,276,1.19 [0.97-1.46],0.0902384548959378
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27501,1142,1.08 [0.98-1.20],0.1356407442307669
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Mycoses,27606,356,1.19 [1.01-1.41],0.0431476753257644
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26882,588,1.21 [1.05-1.38],0.0072553672808294
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27549,689,1.13 [1.00-1.29],0.0544067673897128
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26503,144,1.35 [1.02-1.77],0.0338054096388377
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,27646,33,0.69 [0.37-1.29],0.2417074416920768
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27465,605,1.15 [1.00-1.31],0.0462732525028653
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27490,70,1.26 [0.85-1.89],0.2512872876734228
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27553,168,1.16 [0.89-1.52],0.2625495366362333
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27538,153,1.21 [0.92-1.59],0.1689842951742096
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26622,328,1.11 [0.93-1.34],0.2490968946904565
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,26527,233,1.17 [0.94-1.47],0.1621966274551393
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,26437,78,1.33 [0.92-1.94],0.131891235404714
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,27617,54,1.03 [0.65-1.63],0.9107316324609136
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27584,127,0.94 [0.69-1.29],0.7017315649769276
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral warts,27501,44,0.78 [0.45-1.35],0.3681845553083256
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],27506,49,1.00 [0.60-1.66],0.9995863986904856
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm,27359,315,1.06 [0.87-1.29],0.587640293141471
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27555,75,1.30 [0.88-1.93],0.1903393502371165
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27536,79,1.15 [0.78-1.68],0.4849490511501964
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,12319,44,0.84 [0.48-1.47],0.5326013367653336
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27453,1174,1.14 [1.03-1.26],0.008805521603897
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of meninges,27634,46,1.51 [0.93-2.43],0.0929612371770208
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27611,49,0.83 [0.49-1.41],0.4947261668987561
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,27624,87,1.59 [1.13-2.24],0.0075680126018223
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of ovary,15267,98,1.38 [0.98-1.93],0.0616901542645553
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,27639,270,1.05 [0.85-1.30],0.6370299118031677
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Caecum,27635,205,1.02 [0.80-1.31],0.8578303492823702
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27578,57,1.40 [0.92-2.13],0.1171869328236719
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Descending colon,27638,173,1.22 [0.95-1.55],0.1188110749320722
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Rectum,27602,288,1.19 [0.98-1.45],0.0808286805148472
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27572,539,1.21 [1.05-1.39],0.0096714391368521
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,27639,309,1.20 [1.00-1.46],0.0537103162888149
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Carcinoma in situ of breast,13139,87,1.09 [0.74-1.61],0.6467906626190306
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",13187,100,1.10 [0.76-1.57],0.6162094713184793
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",23902,31,1.45 [0.81-2.58],0.2129615053410583
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",23908,37,1.16 [0.65-2.06],0.6201351573371843
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27606,109,0.69 [0.49-0.99],0.0424372024932206
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Haemangioma, any site",27606,107,0.71 [0.50-1.02],0.062071375844031
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Leiomyoma of uterus,14633,414,0.96 [0.80-1.15],0.6468324746868477
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Lung cancer and mesothelioma,20569,176,1.81 [1.49-2.20],1.777590197916363e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Lymphoid leukaemia,23900,29,1.61 [0.90-2.86],0.1057195701322979
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24018,147,1.00 [0.74-1.36],0.981988113220146
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",23956,85,1.25 [0.88-1.78],0.214362666491733
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",13241,84,1.01 [0.68-1.50],0.9453910383363372
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",23922,51,0.93 [0.58-1.50],0.7734001337824363
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",23934,63,1.26 [0.81-1.95],0.2990496930564414
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",23940,69,1.41 [0.97-2.03],0.0690996873402241
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",13210,53,1.10 [0.69-1.75],0.68404127364804
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",23927,56,0.58 [0.35-0.96],0.0355330064030105
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11123,409,1.17 [0.98-1.39],0.0805122073096037
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",23957,86,1.48 [1.05-2.07],0.0232814728178052
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",23925,54,1.52 [0.99-2.34],0.0562091953134306
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,23935,64,1.66 [1.12-2.44],0.011164157567595
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanocytic naevi,27407,212,0.99 [0.78-1.27],0.9590763531611006
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanocytic naevi of trunk,27597,93,1.20 [0.84-1.72],0.3083602901510646
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanoma in situ,23885,50,0.74 [0.42-1.28],0.2798477241411847
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",23929,58,1.17 [0.74-1.83],0.5043321815856618
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",23987,116,1.31 [0.96-1.78],0.0840655410258479
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",23993,122,1.41 [1.02-1.95],0.0376516067063224
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",23939,68,1.67 [1.15-2.42],0.0065889487556109
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Other benign neoplasms of skin,27463,135,1.19 [0.89-1.60],0.2359595162108554
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",24512,641,1.09 [0.94-1.25],0.2540878163802729
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",24542,671,1.07 [0.93-1.23],0.3210450151092496
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27379,280,1.08 [0.88-1.33],0.4724570699957283
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,26240,57,1.00 [0.64-1.57],0.9986430929163336
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27167,68,1.31 [0.88-1.96],0.1853457913569174
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26851,2216,1.12 [1.04-1.20],0.0025899232782639
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,26462,24,1.85 [1.00-3.44],0.0515975994724621
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27296,36,0.77 [0.41-1.43],0.4031858340330015
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27202,1019,1.16 [1.05-1.29],0.0050735934951116
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27202,1019,1.16 [1.05-1.29],0.0050735934951116
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,26240,57,1.54 [1.03-2.31],0.0345082836853095
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27362,924,1.18 [1.05-1.32],0.0048865422704678
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,27373,113,1.42 [1.04-1.93],0.0274253857680553
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27152,53,1.33 [0.87-2.04],0.1860727473376975
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27142,43,1.51 [0.94-2.42],0.0864204291627313
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,27450,190,1.30 [1.02-1.65],0.0341882235763158
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27568,69,1.46 [0.98-2.17],0.0629077855493822
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",27418,158,1.31 [1.01-1.71],0.0425357839583834
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,26513,75,0.96 [0.65-1.44],0.8561667525551244
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,23760,208,1.21 [0.97-1.53],0.0940538260222569
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,25720,128,0.95 [0.72-1.26],0.7414425256099935
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,25728,136,1.12 [0.81-1.55],0.4930288022295398
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,23590,38,1.81 [1.14-2.87],0.0123610593584965
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,25670,70,1.57 [1.10-2.24],0.0120256702981354
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25337,150,1.12 [0.84-1.48],0.4444505751344597
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",27500,165,1.30 [1.01-1.66],0.03965423766584
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,27380,45,1.60 [0.99-2.57],0.0527731957595099
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,27371,36,0.73 [0.39-1.36],0.321941410929302
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27237,1637,1.04 [0.95-1.13],0.4072118276817401
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,24753,1587,1.09 [1.00-1.18],0.0503761025323811
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",23592,40,1.22 [0.71-2.09],0.4740910569595521
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",25968,58,0.83 [0.51-1.33],0.4279949722475054
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,23738,186,1.24 [0.97-1.57],0.0818823284541448
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,23616,64,0.94 [0.59-1.48],0.7863455547207094
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,25937,2385,1.13 [1.06-1.22],0.0005386921680896
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,23670,118,1.24 [0.91-1.67],0.1680347555563552
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,23939,387,1.12 [0.94-1.33],0.1908159558275678
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27545,269,1.27 [1.03-1.56],0.0232880319608037
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,27384,108,0.95 [0.67-1.34],0.7549087935888892
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,23650,98,0.94 [0.65-1.34],0.7256228910527562
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",23592,40,1.37 [0.81-2.31],0.2428978542693858
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27217,1307,1.09 [0.99-1.20],0.0915453741865927
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,23678,126,1.59 [1.21-2.09],0.0009562159612507
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,23713,161,1.19 [0.91-1.56],0.2066871715853154
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",23939,387,1.28 [1.08-1.52],0.0046415661697938
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,23611,59,1.01 [0.64-1.60],0.9729366975242428
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,27377,101,0.88 [0.61-1.27],0.4926202666734938
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,23850,298,1.25 [1.03-1.51],0.0214512467710379
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,23852,300,1.25 [1.04-1.51],0.0199376591123207
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,25245,58,1.04 [0.66-1.65],0.8625868146288196
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,26961,3409,1.16 [1.10-1.23],4.201029492707112e-07
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,25948,38,2.37 [1.55-3.62],6.304270907302089e-05
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,25969,59,1.12 [0.71-1.75],0.6276301077553297
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,27464,1923,1.11 [1.02-1.20],0.0134900907756441
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",27468,1920,1.11 [1.02-1.20],0.0133168791395559
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,25947,37,1.33 [0.75-2.34],0.3281507588991453
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27321,1238,1.09 [0.99-1.20],0.0775272487616599
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",24441,889,1.23 [1.10-1.37],0.0001973180858267
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,27636,136,1.01 [0.75-1.36],0.9360527566014384
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,27370,35,2.33 [1.46-3.69],0.000345270186128
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,26169,86,1.00 [0.70-1.44],0.998659463445926
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,26201,118,0.73 [0.52-1.02],0.0640054047337042
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",23683,131,1.49 [1.12-1.99],0.0068612281909559
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25868,119,1.33 [0.98-1.81],0.0710043284569722
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1685,69,0.98 [0.65-1.47],0.9046737272222122
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1794,193,0.80 [0.62-1.03],0.0810757518096878
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,25789,40,1.06 [0.63-1.79],0.8184187812065071
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1653,37,1.02 [0.58-1.79],0.9505131599925136
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27226,1477,1.08 [0.99-1.19],0.0767143733127231
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,27405,70,1.58 [1.09-2.30],0.0166460659333551
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,25461,274,1.22 [0.99-1.49],0.0577361090294117
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,23960,408,1.28 [1.08-1.50],0.0032899776899295
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27558,177,1.05 [0.82-1.36],0.6848316382967699
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),26922,55,1.31 [0.87-1.98],0.1959158816035111
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Angina pectoris,26371,785,1.22 [1.08-1.38],0.001062201901213
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,26968,101,1.24 [0.90-1.71],0.1892659890500973
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,26898,31,1.35 [0.82-2.24],0.2428292720502156
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",26971,104,1.78 [1.35-2.35],4.245705155875096e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,19733,930,1.25 [1.12-1.39],6.858291077657665e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,AV-block,25188,180,1.07 [0.83-1.39],0.5840111403171457
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27615,257,1.18 [0.96-1.45],0.1223503780700953
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Cardiac arrest,18921,118,1.56 [1.16-2.09],0.0029753491422812
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25145,137,1.16 [0.86-1.56],0.3248143881045384
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",25090,82,0.85 [0.57-1.26],0.4192077802618822
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,27648,20,1.42 [0.73-2.78],0.3029928909040964
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Conduction disorders,25532,524,1.23 [1.07-1.43],0.0048243508513792
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26931,1355,1.26 [1.15-1.38],4.0488609060718093e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,25705,5998,1.07 [1.02-1.12],0.0045439385736515
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26488,186,1.10 [0.86-1.41],0.4281006298849484
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Endocarditis,25049,41,1.84 [1.13-3.01],0.0146741414781138
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27530,505,1.31 [1.13-1.51],0.0002299643773948
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypertension,26277,4884,1.07 [1.01-1.12],0.0121276996274127
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",26293,4900,1.07 [1.01-1.12],0.0133444987604454
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27481,56,1.19 [0.77-1.84],0.4314729077657138
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",21481,88,2.92 [2.25-3.80],8.552238762366032e-16
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21455,62,1.04 [0.66-1.64],0.8630540680068584
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypotension,27543,689,1.17 [1.03-1.32],0.0151783420417472
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,27122,65,0.89 [0.58-1.35],0.5775145061173355
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27086,1500,1.21 [1.11-1.32],2.1622864275063173e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27420,304,1.23 [1.02-1.48],0.0294953346942658
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,25197,189,1.28 [1.00-1.64],0.0458168143793309
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27393,596,1.30 [1.14-1.48],0.0001073338943126
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26072,486,1.40 [1.21-1.61],4.422303821464847e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27593,116,1.68 [1.29-2.20],0.0001366481537925
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",27633,206,1.36 [1.09-1.70],0.0066961746488664
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Oesophageal varices,26343,41,1.08 [0.63-1.87],0.7694162504595294
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other aneurysm,26916,49,0.80 [0.48-1.34],0.3935720624630776
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,25248,240,1.22 [0.98-1.52],0.0757909486430335
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,26931,64,1.41 [0.99-2.00],0.0563416518617317
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27003,136,1.26 [0.96-1.66],0.0973655048673348
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,25137,129,1.45 [1.10-1.92],0.0084194608546471
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other disorders of veins,26376,74,0.89 [0.59-1.34],0.5801576297036927
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,26349,47,0.71 [0.42-1.19],0.187765108767901
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,26869,34,1.17 [0.64-2.14],0.6026224749249913
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,26390,88,1.17 [0.82-1.66],0.3901075388094617
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25586,578,1.33 [1.15-1.52],6.492758200716148e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,26899,45,0.95 [0.57-1.58],0.8512608989823571
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27205,338,1.56 [1.32-1.83],1.420173099188839e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27205,159,2.58 [2.10-3.16],1.2716275755127105e-19
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27069,234,1.03 [0.82-1.29],0.7999896154758562
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19052,249,1.23 [0.99-1.52],0.0603320561564855
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27045,204,1.73 [1.42-2.11],6.714338146420329e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26559,257,1.09 [0.88-1.34],0.4203838276749482
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27383,337,1.09 [0.91-1.31],0.3601990453365781
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27607,331,1.38 [1.16-1.65],0.0003307027912543
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,25182,174,1.24 [0.96-1.60],0.1046381723299322
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27201,155,2.59 [2.10-3.18],2.175457650511264e-19
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,26953,118,1.27 [0.95-1.70],0.1080919781596097
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27413,356,1.19 [1.00-1.41],0.0513917307148652
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27387,391,1.20 [1.02-1.41],0.0267265728192289
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,27098,54,1.15 [0.76-1.76],0.506104507767974
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,26919,53,1.15 [0.72-1.85],0.5605097032774109
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27257,141,1.24 [0.93-1.64],0.142970104359238
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26976,179,1.20 [0.94-1.54],0.1495140000705596
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Varicose veins,26620,318,1.04 [0.85-1.27],0.6963103608938848
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,26877,49,1.12 [0.71-1.76],0.6225853848804555
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27474,532,1.07 [0.93-1.24],0.3523450369266693
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27491,378,0.94 [0.79-1.11],0.4489492328120789
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24644,1422,1.16 [1.06-1.27],0.0011200134141398
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Any mental disorder,26895,3673,1.19 [1.13-1.25],7.253407694618933e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27427,447,0.93 [0.80-1.08],0.354395707753013
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24888,1666,1.11 [1.02-1.21],0.011465104114355
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23317,95,1.10 [0.78-1.55],0.5950609589348779
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Smoking dependency,27111,1524,1.42 [1.33-1.52],9.341830534957116e-26
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",24989,1767,1.55 [1.46-1.64],1.912134058703543e-52
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Vascular dementia,27535,21,2.50 [1.35-4.60],0.0033535931987386
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Alzheimer disease,27648,63,1.48 [0.98-2.24],0.0647708679861929
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Bell's palsy,25996,73,1.13 [0.76-1.70],0.5454605253624463
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26389,466,1.03 [0.88-1.21],0.714619970095923
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Cerebral cysts,27296,206,1.04 [0.81-1.32],0.7679350500179647
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27565,225,0.99 [0.78-1.25],0.9241492339181042
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,27510,23,0.67 [0.31-1.42],0.2913887602469649
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,27634,52,1.75 [1.13-2.71],0.0128046102152101
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27148,58,0.68 [0.42-1.11],0.124923574260211
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Epilepsy,26082,257,1.11 [0.90-1.37],0.3301159483849989
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27160,1335,1.03 [0.93-1.13],0.5998194810771751
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,27618,269,0.87 [0.70-1.09],0.2305987954326927
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27136,1645,1.06 [0.97-1.15],0.1788860806467868
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Generalized epilepsy,27275,50,1.74 [1.15-2.65],0.0091320338966409
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Hemiplegia,27502,162,1.10 [0.84-1.43],0.4946276215699579
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Hydrocephalus,27136,46,1.44 [0.92-2.24],0.1088154444124183
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,27625,60,1.28 [0.85-1.95],0.2396148453215922
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,26000,77,0.99 [0.65-1.49],0.9508349098087292
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,26005,82,1.25 [0.88-1.77],0.2075022817412569
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Memory loss,27501,73,0.97 [0.65-1.45],0.8960072091717315
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Migraine,26252,427,1.03 [0.87-1.23],0.7273124924003211
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27555,380,1.00 [0.83-1.20],0.9817030980452788
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Motor neuron disease,20129,96,1.00 [0.70-1.43],0.998064888871528
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27454,144,1.17 [0.89-1.53],0.2507286104412852
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27039,1116,1.05 [0.94-1.16],0.3749441473316549
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Neurological diseases,26219,3055,1.03 [0.97-1.10],0.358586652629004
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,27560,73,0.84 [0.55-1.27],0.4051342050200749
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26311,388,1.07 [0.90-1.27],0.4600419881809127
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",27576,235,1.21 [0.98-1.50],0.0830429466344447
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23070,302,1.09 [0.90-1.33],0.3738175854714289
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27150,60,1.22 [0.79-1.89],0.3663119888726758
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27203,113,0.89 [0.64-1.25],0.4981789384188694
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,27439,90,1.29 [0.92-1.81],0.133044550638664
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,26013,90,1.03 [0.71-1.49],0.8936839833847903
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other headache syndromes,25883,58,0.93 [0.58-1.48],0.7547827719488966
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other neurological diseases,27528,438,1.06 [0.90-1.24],0.5212996259710576
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other sleep disorders,26399,574,0.96 [0.83-1.12],0.6133975524675159
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Parkinson's disease,27635,157,0.70 [0.51-0.96],0.0263360767780792
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27154,64,0.85 [0.53-1.37],0.5144426862249354
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Restless leg syndrome,27647,45,1.49 [0.94-2.36],0.0872846507038247
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Sleep apnoea,27404,500,0.95 [0.81-1.12],0.5328586169528009
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,27377,36,1.30 [0.75-2.26],0.3530636656821474
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,27634,122,1.00 [0.73-1.36],0.999491063786336
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,25954,31,1.19 [0.65-2.18],0.5689801104815922
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,27648,64,1.43 [0.94-2.17],0.0910721915793586
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),27523,20,2.40 [1.27-4.53],0.0067414005312063
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27166,43,1.62 [1.00-2.62],0.047968492685223
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27303,218,0.99 [0.77-1.26],0.9100994385221336
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27558,195,0.68 [0.51-0.89],0.0046913932397774
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,26901,37,0.78 [0.43-1.40],0.4011514270818785
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26939,75,1.14 [0.77-1.68],0.5212634849178981
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27561,30,0.53 [0.26-1.09],0.0825091629408954
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,27446,66,0.91 [0.58-1.42],0.6801216266938928
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1660,44,1.09 [0.65-1.83],0.7318465870724544
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1965,85,0.92 [0.64-1.33],0.6650926347071145
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27200,77,1.01 [0.68-1.50],0.9697380793848596
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27520,618,0.80 [0.69-0.93],0.004198024962016
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27337,473,1.17 [1.00-1.36],0.0516297509172894
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26999,135,1.21 [0.90-1.63],0.2063124804603781
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27556,471,1.10 [0.94-1.29],0.2509603815909769
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,27635,50,1.51 [0.96-2.40],0.0771018279882255
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,27484,399,1.13 [0.95-1.35],0.1678422085631049
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",27604,224,1.03 [0.81-1.31],0.8040455292002779
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27585,127,0.67 [0.48-0.94],0.0214537894957131
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,26882,18,1.83 [0.88-3.80],0.1042443669995526
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,26893,29,0.81 [0.42-1.56],0.5252641437428311
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,26896,32,1.82 [1.08-3.08],0.0255625394020362
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27600,384,0.99 [0.83-1.19],0.9558556347654336
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27316,100,1.18 [0.83-1.68],0.3620713183434393
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,27109,24,0.80 [0.37-1.71],0.5609658706347835
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,27454,74,0.73 [0.47-1.14],0.1694090756184468
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,27530,150,1.24 [0.94-1.64],0.1351509867019475
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,27244,159,1.34 [1.03-1.76],0.0316001553060856
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,27534,76,0.66 [0.42-1.04],0.0745959826089434
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27469,253,0.99 [0.79-1.23],0.9146857861355818
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27238,115,0.72 [0.51-1.02],0.0656838207795297
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,26929,1041,1.03 [0.93-1.15],0.5652745235730603
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,27503,123,1.16 [0.85-1.59],0.345927323034228
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,27621,113,1.22 [0.88-1.68],0.2249559169359097
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27123,259,1.22 [0.99-1.50],0.0638828803998332
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,27416,36,0.79 [0.43-1.45],0.4472438662025511
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,27620,35,1.51 [0.86-2.65],0.1499415320860614
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,26903,39,0.96 [0.54-1.71],0.9008637794055224
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26978,114,1.26 [0.92-1.71],0.1431734161504229
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,26971,69,0.61 [0.39-0.97],0.0360658460738396
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,27143,58,1.03 [0.65-1.64],0.8853763607468286
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",26952,50,0.67 [0.39-1.18],0.1651121363540953
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,27273,57,1.08 [0.68-1.71],0.7459295004111359
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",27309,93,1.13 [0.78-1.63],0.5280973764960235
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,26951,87,1.45 [1.01-2.08],0.0434491276397526
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,27024,122,0.86 [0.61-1.21],0.3809670762197554
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,26937,35,1.06 [0.61-1.84],0.8373042298790416
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,26717,829,1.15 [1.01-1.29],0.0277665778743573
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,26912,48,0.85 [0.49-1.45],0.5457169735519
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27432,309,0.99 [0.81-1.21],0.9123365216166596
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27162,39,1.34 [0.80-2.26],0.2678078413478658
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27252,129,1.12 [0.83-1.51],0.4521871468973057
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,27453,61,0.91 [0.57-1.47],0.704982443765009
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,27605,97,0.78 [0.54-1.12],0.1768476019046775
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27527,133,0.99 [0.73-1.34],0.9317091429096336
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,27444,52,1.58 [1.02-2.43],0.0403499570068264
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,27444,52,1.08 [0.67-1.74],0.7558957765954245
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27557,526,0.97 [0.83-1.13],0.677951973897674
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,27357,326,0.98 [0.80-1.19],0.812423816615115
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,27126,95,0.90 [0.62-1.31],0.5725459997568224
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,27113,82,1.18 [0.81-1.71],0.3979576274630143
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Acute pharyngitis,27359,80,1.80 [1.30-2.49],0.0004042717083318
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27514,235,1.14 [0.91-1.42],0.2548151290445266
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,27342,63,1.10 [0.72-1.68],0.6687931630077544
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,All influenza,26350,75,1.53 [1.08-2.17],0.0161864286982989
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),26348,73,1.56 [1.10-2.22],0.0134459861262215
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),20516,123,1.72 [1.27-2.31],0.0003878660440146
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Allergic rhinitis,27497,308,0.89 [0.72-1.10],0.2693758024916346
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21992,1738,1.16 [1.07-1.26],0.0005326392491602
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",22102,1709,1.16 [1.06-1.26],0.0009038564941272
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),27369,93,1.38 [1.01-1.88],0.0400288273137845
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",26331,56,1.75 [1.20-2.53],0.003234317812845
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Bronchiectasis,24640,185,1.33 [1.05-1.69],0.0180956398956409
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",24497,42,1.00 [0.60-1.68],0.9977312362077316
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26793,2338,1.23 [1.15-1.31],2.5790727064440036e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26178,67,0.89 [0.57-1.38],0.5956701094074953
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,26277,166,0.93 [0.71-1.22],0.6051751587140464
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27545,718,1.39 [1.25-1.54],5.3635690168237e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,26241,130,0.83 [0.60-1.15],0.262764581565754
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25747,4243,1.12 [1.06-1.18],1.5641953350605702e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26493,382,1.09 [0.92-1.30],0.3355483799385144
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Early onset COPD,27328,501,1.46 [1.29-1.64],1.1851970284153587e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Emphysema,24642,187,1.88 [1.59-2.22],1.8678815685993786e-13
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26404,112,2.67 [2.11-3.37],1.6314443477892998e-16
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27465,1190,1.22 [1.12-1.34],2.0700005135747145e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,26427,135,2.37 [1.89-2.97],8.479466624423867e-14
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Later onset COPD,26230,217,1.25 [1.02-1.53],0.0279823663936303
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,27640,155,1.17 [0.90-1.52],0.2375579738293541
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Nasal polyp,26219,108,0.80 [0.56-1.13],0.2006478147074922
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27442,605,1.16 [1.01-1.32],0.0315350610784452
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,27472,1225,1.24 [1.14-1.36],2.9231605163354e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26997,886,1.03 [0.92-1.16],0.572711280801592
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other pleural conditions,26281,34,1.43 [0.82-2.47],0.2050564665542233
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27594,195,2.11 [1.73-2.58],1.179148368661968e-13
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27566,840,1.29 [1.15-1.43],6.589051268124579e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pleural effusion,26825,578,1.21 [1.06-1.38],0.0060850880859753
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pleural plaque,26300,53,1.18 [0.74-1.87],0.4823643423367558
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27263,988,1.23 [1.11-1.36],7.367476240292725e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,27621,136,1.01 [0.76-1.35],0.929025522665078
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pneumothorax,26311,64,1.28 [0.86-1.90],0.2210161235703375
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pollen allergy,27613,265,0.78 [0.62-0.98],0.0344958746634721
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pulmonary oedema,27436,37,1.51 [0.93-2.47],0.0979208343610095
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,20431,38,1.75 [1.09-2.80],0.0206846612634068
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27425,588,1.15 [1.00-1.32],0.0447995065227953
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26419,308,0.89 [0.72-1.10],0.2786354408325586
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Viral pneumonia,26460,185,1.13 [0.88-1.45],0.3512252811750517
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",27388,159,1.10 [0.84-1.45],0.4922786389747879
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,15979,101,1.47 [1.07-2.01],0.0159648745557058
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21176,65,1.10 [0.74-1.65],0.6348629692381125
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute appendicitis,27449,160,0.96 [0.72-1.27],0.7744663190658803
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute gastritis,22109,74,0.94 [0.63-1.40],0.7561614533011475
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,26062,158,0.94 [0.72-1.24],0.6799540946392382
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute peritonitis,27216,73,1.17 [0.80-1.72],0.4225821991868441
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,26868,82,1.08 [0.77-1.51],0.6525329182086963
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Barrett oesophagus,22381,346,0.95 [0.79-1.16],0.635369293020636
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",25958,54,0.73 [0.45-1.19],0.2113280752638201
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27240,54,0.73 [0.45-1.19],0.2111639599384587
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Cholecystitis,26081,177,1.01 [0.78-1.32],0.9113093001436978
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Cholelithiasis,26812,908,0.95 [0.84-1.07],0.36308369090947
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Chronic gastritis,22289,254,1.00 [0.80-1.25],0.9877100302399752
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,25947,43,0.99 [0.62-1.58],0.959695602056432
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27502,77,1.09 [0.75-1.59],0.6580118045772139
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Coeliac disease,26237,117,0.90 [0.64-1.28],0.5660381808666088
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Collagenous colitis,26082,57,1.24 [0.81-1.89],0.3149062448997367
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27465,208,1.11 [0.87-1.40],0.4036711811156901
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Constipation,27428,1171,1.01 [0.91-1.12],0.81650415454928
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Crohn disease,26121,96,1.03 [0.72-1.47],0.8617865192072421
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27302,67,0.99 [0.65-1.53],0.9810372952388724
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26118,93,0.95 [0.66-1.37],0.7980076600009003
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Dental caries,26813,258,0.98 [0.80-1.21],0.8662136632649379
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,25587,1828,0.98 [0.91-1.07],0.7055475895095229
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of appendix,27490,201,1.01 [0.78-1.29],0.9654873393966348
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of liver,27531,745,1.01 [0.89-1.14],0.928339383311334
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",25931,3896,1.03 [0.97-1.09],0.3360655094750604
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27158,603,1.00 [0.87-1.14],0.9667756431124712
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27566,423,1.08 [0.92-1.28],0.343194151588896
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26681,126,0.92 [0.68-1.25],0.5879961035977553
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26522,71,0.94 [0.62-1.41],0.7593443372395374
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27374,1254,1.04 [0.94-1.14],0.4623681835559261
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of tongue,26536,123,0.98 [0.72-1.34],0.9084152617217268
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27136,1232,0.98 [0.89-1.09],0.7629876915071405
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,23550,2439,0.97 [0.91-1.05],0.4825195810357862
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,22180,145,1.24 [0.95-1.62],0.1166052063955074
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27579,114,1.19 [0.88-1.61],0.2475270873456267
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27508,80,0.78 [0.51-1.18],0.2336469106771697
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,26884,98,0.99 [0.70-1.40],0.9400764435742656
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21291,180,1.08 [0.84-1.40],0.5379236880741834
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,22553,518,0.93 [0.80-1.09],0.3700902381112082
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastric ulcer,22312,277,0.92 [0.75-1.13],0.4337699556289787
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,24278,2243,1.07 [1.00-1.15],0.0653989364780934
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22439,404,1.00 [0.85-1.19],0.9750166041407804
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,22586,8076,1.02 [0.98-1.06],0.3433720795566796
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,GI-bleeding,27132,1012,1.03 [0.92-1.14],0.6418082036848156
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,26615,60,0.91 [0.59-1.41],0.6823302466768899
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,22037,1290,1.06 [0.96-1.17],0.2291603836691727
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",26841,55,1.40 [0.93-2.11],0.1091964197237452
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Hernia,26494,2735,0.97 [0.91-1.04],0.3942590710496164
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Impacted teeth,27517,74,0.92 [0.60-1.40],0.6913784782487654
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Impaction of intestines,21145,34,0.88 [0.48-1.61],0.6699844830248824
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Inguinal hernia,24429,670,0.83 [0.72-0.96],0.0121741504729541
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",23838,79,0.94 [0.63-1.42],0.7833295363037289
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,21185,74,1.16 [0.79-1.71],0.4490979414609434
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26256,136,0.95 [0.70-1.31],0.7700205230687964
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,21682,571,1.08 [0.93-1.25],0.3130567658012856
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,27623,391,1.05 [0.88-1.25],0.5802628865938422
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26721,696,1.04 [0.91-1.18],0.6012901751086268
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26908,883,1.07 [0.95-1.20],0.2639281385599762
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22187,152,1.08 [0.82-1.42],0.6007952028064258
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oesophagitis,22525,490,1.16 [0.99-1.35],0.0639104036431034
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27604,132,1.07 [0.80-1.44],0.6315023781133942
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23804,45,1.51 [0.96-2.39],0.0760134922688534
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22409,1298,1.13 [1.03-1.24],0.0133485637091133
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26101,197,0.86 [0.67-1.10],0.2206197576114976
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,26066,162,1.02 [0.78-1.34],0.8886600727970356
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,22626,1515,1.10 [1.01-1.20],0.0300410442559264
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,26008,4897,1.04 [0.99-1.09],0.1575002181712593
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26526,194,1.04 [0.81-1.33],0.7699830430255626
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of liver,27389,603,1.00 [0.86-1.15],0.945499384449838
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,22568,533,1.10 [0.95-1.28],0.1997148679857026
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,25984,80,1.41 [1.00-1.98],0.0474554766108357
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27509,366,1.06 [0.88-1.27],0.5516677384100095
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22808,773,1.05 [0.92-1.19],0.4753910505868594
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27144,1024,1.04 [0.93-1.16],0.5075471926395573
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26735,180,1.12 [0.87-1.44],0.365618678523862
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,22324,1213,1.04 [0.94-1.15],0.443144754132477
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),23831,1796,1.06 [0.98-1.15],0.1657637312809084
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,26865,79,1.22 [0.83-1.79],0.3173602376842428
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26796,771,1.07 [0.95-1.22],0.259196787671551
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21340,229,1.22 [0.98-1.52],0.0744628934365264
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27493,94,0.73 [0.50-1.08],0.1165421729773684
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21457,346,1.13 [0.94-1.36],0.1915646681071158
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26256,136,1.00 [0.75-1.35],0.9924717872340412
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,27638,58,1.09 [0.69-1.72],0.7135726548118426
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26571,124,1.15 [0.85-1.55],0.3754291647556906
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Toxic colitis,26057,32,0.88 [0.47-1.66],0.6973151827583868
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22219,184,0.97 [0.75-1.25],0.8126997992143772
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,26169,144,0.93 [0.69-1.26],0.6468725122289141
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26151,126,0.88 [0.64-1.22],0.4532210560840747
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Umbilical hernia,24038,279,0.90 [0.73-1.12],0.3383384167626301
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,21214,103,1.02 [0.73-1.42],0.9071288763002668
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ventral hernia,23981,222,1.15 [0.92-1.44],0.2289464525933708
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Volvulus,21175,64,1.19 [0.79-1.80],0.4138137491700242
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27593,159,0.93 [0.69-1.25],0.6342794915255303
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,27374,76,0.94 [0.63-1.41],0.7766165187001897
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26163,149,1.07 [0.80-1.43],0.6677466259704467
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27021,545,1.03 [0.89-1.19],0.6766454929677044
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26673,197,0.95 [0.75-1.21],0.6804065216195532
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,26185,171,1.19 [0.93-1.52],0.165329571899072
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,27385,226,1.15 [0.92-1.44],0.2126728832905258
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27550,391,1.07 [0.90-1.27],0.4572481752486083
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27206,47,1.09 [0.65-1.82],0.7369763730574872
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26180,2582,1.12 [1.05-1.20],0.0008551567549331
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27188,443,1.20 [1.03-1.41],0.0232446929111354
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27062,317,1.26 [1.05-1.51],0.0143385744814843
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27261,785,1.02 [0.90-1.15],0.7683490178854181
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",27636,46,1.36 [0.82-2.26],0.2305277044207942
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,26071,57,1.76 [1.19-2.60],0.0045463405007746
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26787,42,1.10 [0.64-1.88],0.7409344650368594
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,27379,220,1.13 [0.89-1.42],0.3121902994817358
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26305,291,1.22 [1.00-1.49],0.0525574202631233
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,26047,33,1.31 [0.73-2.33],0.3672079043757145
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27564,70,0.97 [0.64-1.46],0.8656137719897995
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,26615,139,0.90 [0.67-1.21],0.4816161870453633
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27455,157,1.18 [0.90-1.54],0.2294905041111149
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27190,31,0.81 [0.44-1.50],0.5052712733362131
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,26065,51,0.83 [0.48-1.43],0.5024953769562592
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27121,1107,1.12 [1.01-1.24],0.0326093374580991
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26336,322,1.21 [1.00-1.46],0.050511698651774
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,26051,37,1.47 [0.87-2.46],0.1475658960298559
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27564,266,1.20 [0.98-1.48],0.0787929567609154
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27220,61,1.04 [0.67-1.60],0.8734675168486006
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27517,219,1.17 [0.93-1.46],0.1706328540626309
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27616,182,0.96 [0.73-1.25],0.7421691562502593
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26139,125,1.04 [0.76-1.44],0.790990240425308
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26207,193,0.85 [0.65-1.11],0.2304873279933592
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27607,173,0.94 [0.71-1.24],0.6671946356872241
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",26144,130,1.14 [0.86-1.52],0.3482633558624292
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,27614,120,1.15 [0.84-1.57],0.3752388698856973
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,24275,134,1.09 [0.80-1.47],0.5898392029874595
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,25824,4659,1.03 [0.98-1.08],0.2980030930462297
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,24458,3293,1.01 [0.95-1.08],0.7311895487704241
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,24236,95,0.81 [0.56-1.19],0.2830849439179531
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,24824,153,1.13 [0.86-1.48],0.3695300874720416
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,24832,161,1.00 [0.76-1.32],0.9906661977713888
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,27418,115,1.04 [0.75-1.43],0.8230751711938775
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",24717,46,1.38 [0.87-2.19],0.1713549579372169
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,21913,748,0.97 [0.85-1.10],0.6139267002478898
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27589,123,0.87 [0.63-1.21],0.4043859230704963
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24965,294,1.13 [0.93-1.38],0.2256234409889928
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,24195,6249,1.01 [0.96-1.05],0.7121162768369013
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26286,109,0.84 [0.59-1.18],0.3088296347108337
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,24253,112,0.78 [0.56-1.08],0.1360916990808237
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24753,612,0.99 [0.86-1.15],0.9015859955987748
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26765,2094,1.03 [0.95-1.11],0.4822052328404187
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24366,225,1.00 [0.79-1.26],0.9749511989139756
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,24418,277,1.26 [1.03-1.53],0.0230891797794446
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24291,150,0.77 [0.57-1.05],0.0978218326197318
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,27135,35,0.98 [0.54-1.81],0.9564322537325132
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,22481,1316,0.95 [0.86-1.05],0.352108627488237
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21560,395,1.08 [0.90-1.29],0.4237672962897162
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27596,385,1.06 [0.88-1.27],0.5512961705121807
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21233,68,0.88 [0.55-1.41],0.593573509406388
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),21517,352,1.05 [0.87-1.27],0.6176893319051471
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24471,330,0.91 [0.74-1.11],0.3504787682974697
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,21927,762,1.01 [0.89-1.15],0.8864340807599954
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,24699,28,2.34 [1.46-3.73],0.0003748120233737
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25228,557,1.15 [0.99-1.32],0.0652168660294674
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,24957,286,1.09 [0.89-1.34],0.3845130059388703
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,21878,713,1.03 [0.90-1.17],0.717159965025949
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,24224,83,1.18 [0.81-1.72],0.3811842606954518
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",24203,62,1.24 [0.81-1.88],0.3202775038066791
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,26230,53,1.45 [0.94-2.24],0.0891431685160685
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27314,1137,1.03 [0.93-1.14],0.6168111903454647
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26820,643,1.07 [0.93-1.22],0.3616807050277891
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27538,345,1.23 [1.03-1.47],0.0230147555651522
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,22942,1777,1.10 [1.01-1.19],0.0232362552144852
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,21246,81,1.32 [0.90-1.94],0.1545024920450044
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,24221,80,0.93 [0.63-1.36],0.6915733499002861
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,21191,26,0.86 [0.41-1.77],0.6755588464207345
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21277,112,0.94 [0.67-1.34],0.7434722538881062
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,26408,231,0.96 [0.76-1.20],0.7023835843812878
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,26415,238,0.96 [0.76-1.21],0.7303416794972635
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,27606,86,1.43 [1.02-2.01],0.0359470704625024
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26234,1563,1.05 [0.96-1.15],0.2558561748676886
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24257,116,1.03 [0.74-1.43],0.8498458544620473
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21284,119,0.98 [0.70-1.36],0.8973812885511273
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25306,635,1.11 [0.96-1.27],0.1496435822045672
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,23201,2036,1.01 [0.94-1.10],0.7174625046088454
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,27156,56,1.13 [0.71-1.79],0.6104796917957831
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,27622,73,0.97 [0.64-1.46],0.8746739743487895
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24223,82,1.01 [0.70-1.47],0.938281702994038
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25236,1095,1.13 [1.02-1.25],0.0235098977963486
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,24207,66,0.99 [0.65-1.49],0.9446810814562688
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,22276,1111,1.19 [1.07-1.31],0.0008440247863906
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26277,100,1.09 [0.77-1.53],0.6296915660345654
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,24210,69,0.78 [0.49-1.24],0.3001926072125394
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,24788,117,0.88 [0.63-1.23],0.4528644474247695
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24545,404,1.07 [0.90-1.28],0.4223964390373345
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27311,211,1.17 [0.92-1.48],0.1902107046428137
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25135,464,1.01 [0.86-1.19],0.905628640295868
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27547,326,1.17 [0.97-1.40],0.100225727273925
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,27630,38,1.14 [0.65-1.98],0.647009762588205
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24346,205,1.11 [0.86-1.42],0.4255332351356767
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22199,592,1.13 [0.98-1.31],0.0805769570896236
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24644,503,1.09 [0.93-1.27],0.2945697696709207
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24314,173,1.01 [0.77-1.33],0.9231683080997652
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",21202,37,0.80 [0.44-1.44],0.4509233123427743
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,22926,1761,1.12 [1.03-1.22],0.0060031785476195
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,21611,446,0.95 [0.80-1.12],0.5467151523137047
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,27186,86,1.06 [0.72-1.56],0.7628579248197893
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",27571,51,1.70 [1.12-2.57],0.0124564436433906
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",26040,29,1.27 [0.70-2.31],0.438563382604495
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,21239,74,0.99 [0.66-1.48],0.9540567150495596
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,24763,92,1.35 [0.96-1.89],0.0824864766079727
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,21514,349,1.22 [1.02-1.45],0.0269263580459108
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24415,274,1.09 [0.88-1.34],0.4446660702642582
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,24883,212,1.07 [0.84-1.35],0.5952783130356818
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,24782,111,1.13 [0.82-1.56],0.4610344249681123
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,23444,50,1.33 [0.84-2.08],0.2202200724518027
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",27633,41,1.11 [0.65-1.89],0.7107037015211983
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24750,609,0.97 [0.84-1.12],0.7007644109217688
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],27189,89,1.64 [1.18-2.26],0.0030181768259109
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,26556,2415,1.03 [0.95-1.10],0.49298281870821
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24250,109,1.08 [0.78-1.50],0.6352008829897817
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25036,365,1.16 [0.97-1.38],0.1009034736483619
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,26253,185,0.91 [0.70-1.19],0.4913018662139703
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,24820,149,1.20 [0.92-1.58],0.1845946011299032
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25735,1064,1.09 [0.98-1.21],0.0970991159601533
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25378,707,1.06 [0.93-1.21],0.3715872844708788
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],24186,45,0.93 [0.56-1.54],0.7646218961085414
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27242,142,1.25 [0.94-1.65],0.1237561721774336
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24299,158,1.17 [0.89-1.55],0.257486288361014
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,24198,57,1.42 [0.93-2.17],0.1089007391308472
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),21203,38,1.91 [1.19-3.07],0.0075049970406743
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,27082,846,1.20 [1.07-1.34],0.0018089840058081
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11234,76,0.91 [0.59-1.40],0.6695534208897033
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,14940,78,1.20 [0.82-1.77],0.3475839834131227
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27353,325,1.07 [0.88-1.29],0.5132448849287007
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27090,62,0.61 [0.37-1.00],0.0522255081892338
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26931,695,1.25 [1.10-1.42],0.0006632121252287
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,27454,31,1.78 [1.05-3.01],0.0310727149890826
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,27472,189,1.09 [0.85-1.39],0.4970993307172215
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Cystitis,25426,162,0.88 [0.67-1.17],0.3813831286095145
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Dialysis,26297,61,1.18 [0.76-1.82],0.4603692974474972
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,11929,1149,1.10 [1.00-1.23],0.059520353575628
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15067,205,1.10 [0.86-1.41],0.432516648434052
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Endometriosis,11297,139,1.14 [0.85-1.53],0.3979319089835833
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",11544,386,1.05 [0.87-1.26],0.5986304676551565
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11580,422,0.95 [0.79-1.14],0.5862204140187731
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23323,4304,1.05 [1.00-1.11],0.0550075611148226
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,27494,71,1.48 [1.01-2.19],0.0469063495667252
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Hydrocele,10866,86,0.92 [0.61-1.37],0.6689292882953721
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,26148,224,1.03 [0.82-1.31],0.7935343154575394
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11540,760,1.23 [1.08-1.39],0.0012893358746834
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,14932,237,1.03 [0.82-1.28],0.8227314239971014
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),10886,106,1.22 [0.86-1.72],0.259751813144367
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Irregular menses,14936,125,1.14 [0.84-1.56],0.3975653416253604
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11454,296,1.01 [0.82-1.25],0.9150066334190836
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,25328,64,1.39 [0.93-2.07],0.1106087699066895
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12578,1420,1.02 [0.93-1.13],0.6208025276955209
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,10829,49,1.27 [0.79-2.04],0.3211553331193899
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11260,102,0.80 [0.55-1.16],0.2453082683134081
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",27636,37,0.84 [0.46-1.56],0.5861838676313469
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",27643,47,0.83 [0.50-1.38],0.4714421903042766
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26786,1522,1.13 [1.04-1.23],0.0063189378971758
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,25738,474,1.23 [1.06-1.44],0.0076352572489573
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,14928,66,1.04 [0.67-1.61],0.8608073773500164
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27598,315,1.16 [0.96-1.40],0.125693195911819
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,10936,156,1.36 [1.04-1.77],0.0245591378725623
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,10900,120,1.03 [0.74-1.42],0.877626154199719
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,10856,76,0.78 [0.51-1.20],0.256844558014198
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,27611,53,1.03 [0.63-1.67],0.9098927332884122
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26366,1102,1.14 [1.03-1.26],0.0137133626203797
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,14813,118,1.24 [0.91-1.69],0.1679120650525936
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11243,85,0.92 [0.62-1.37],0.6914000604565499
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11383,225,1.10 [0.87-1.40],0.4316284735915446
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11217,59,0.96 [0.61-1.53],0.8667941593767405
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11265,107,1.53 [1.13-2.09],0.0064966139430453
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26180,256,1.03 [0.82-1.28],0.8243309022995057
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,27395,112,1.12 [0.81-1.54],0.5009220004297839
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11344,186,0.96 [0.73-1.25],0.7443340027210152
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11238,80,1.07 [0.71-1.60],0.7528356001832187
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11584,426,1.08 [0.91-1.29],0.3689675787428184
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,11227,69,1.25 [0.82-1.89],0.3030697425364894
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11542,384,1.01 [0.84-1.22],0.8878071642802309
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,27472,49,1.11 [0.69-1.78],0.670047984842981
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",10889,109,0.87 [0.61-1.24],0.4439285658582153
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27442,1518,1.14 [1.04-1.24],0.0032495292906266
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",26063,139,1.13 [0.84-1.52],0.4084059050285378
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,26314,78,0.93 [0.64-1.37],0.7234285337118642
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27099,71,1.04 [0.70-1.55],0.8342266206891129
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,25437,173,1.29 [1.01-1.66],0.04194341141851
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27417,389,1.05 [0.88-1.25],0.5935623052418626
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11259,101,0.99 [0.69-1.41],0.9361913220061994
